The 3 year survival rate of 9 patients who had received VBP chemotherapy suggested by chemosensitivity was 66.7%, and of 5 patients received VAP treatment, it was 53.3%.
根据药敏结果,9例上皮性卵巢癌使用VBP方案化疗,3年生存率66.7%,5例使用VAP方案者3年生存率53.3%。
The median IRs of VBP and VAP to specific histology of epithelial ovarian cancer ( EOC) were 77.3% and 71.0%, respectively.
VBP、VAP方案对上皮性卵巢癌的中位抑制率分别为77.3%和71.0%。
简答网 · 高考英语
简答网 · 中考英语
简答网 · 初中英语作文
简答网 · 双语娱乐资讯